BioNTech SE (BNTX) Shareholder Equity
- 2025-12-31: Retained EarningsEUR 17.96B; Accumulated Other Comprehensive IncomeEUR (m); Noncontrolling InterestsEUR (m).
- 2024-12-31: Retained EarningsEUR 19.10B; Accumulated Other Comprehensive IncomeEUR (m); Noncontrolling InterestsEUR (m).
- 2023-12-31: Retained EarningsEUR 19.76B; Accumulated Other Comprehensive IncomeEUR (m); Noncontrolling InterestsEUR (m).
- 2022-12-31: Retained EarningsEUR 18.83B; Accumulated Other Comprehensive IncomeEUR (m); Noncontrolling InterestsEUR (m).
BioNTech SE Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Retained Earnings EUR | Accumulated Other Comprehensive Income EUR | Noncontrolling Interests EUR |
|---|---|---|---|
| 2025-12-31 | 17.96B | (m) | (m) |
| 2024-12-31 | 19.10B | (m) | (m) |
| 2023-12-31 | 19.76B | (m) | (m) |
| 2022-12-31 | 18.83B | (m) | (m) |
| 2021-12-31 | 9.88B | (m) | (m) |
| 2020-12-31 | 409.60M | -409.63M | (m) |
| 2019-12-31 | (m) | -424.83M | (m) |
| 2018-12-31 | (m) | -245.77M | 847.00K |